Exact Sciences to participate in June 2022 investor conferences
MADISON, Wis., May 27, 2022 /PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that company management will participate in the following conferences and invited investors to participate by webcast.
- William Blair 42nd Annual Growth Stock Conference, Chicago
Presentation on Monday, June 6, 2022 at 3:40 p.m. ET
- Jefferies Healthcare Conference, New York
Fireside Chat on Wednesday, June 8, 2022 at 1:00 p.m. ET
- Goldman Sachs 43rd Annual Global Healthcare Conference, Rancho Palos Verdes
Fireside Chat on Monday, June 13, 2022 at 6:20 p.m. ET
- Nephron Liquid Biopsy Innovation Symposium, virtual
Fireside Chat on Tuesday, June 21, 2022 at 11:00 a.m. ET
The webcasts can be accessed in the investor relations section of Exact Sciences' website at www.exactsciences.com.
About Exact Sciences Corp.
A leading provider of cancer screening and diagnostic tests, Exact Sciences relentlessly pursues smarter solutions providing the clarity to take life-changing action, earlier. Building on the success of Cologuard® and Oncotype® tests, Exact Sciences is investing in its product pipeline to support patients before and throughout their cancer diagnosis and treatment. Exact Sciences unites visionary collaborators to help advance the fight against cancer. For more information, please visit the company's website at www.exactsciences.com, follow Exact Sciences on Twitter @ExactSciences, or find Exact Sciences on Facebook.
Exact Sciences Corp.
View original content to download multimedia:https://www.prnewswire.com/news-releases/exact-sciences-to-participate-in-june-investor-conferences-301556503.html
SOURCE Exact Sciences Corporation
Company Codes: NASDAQ-SMALL:EXAS